AGENT NORMALIZING PANCREAS FUNCTION AND METHOD FOR ITS PREPARING Russian patent published in 2007 - IPC A61K35/55 A61P5/14 

Abstract RU 2302875 C1

FIELD: medicinal industry.

SUBSTANCE: invention relates to a method for isolating biologically active substance from mammalian pancreas and preparing a medicinal formulation for parenteral administration that can be used in medicine as agent normalizing functions of pancreas. Agent is made as a medicinal formulation for parenteral administration and represents peptide complex with the content of low-molecular fraction from 70% to 890%, molecular mass of its peptide components in the range 74-222 Da and the concentration of polypeptides 2.5-2.9 mg/ml. Agent is prepared from calf pancreas (age is 12 months, not above) or pigs by tissue extraction with acetic acid in the presence of zinc chloride. Method for preparing agent from calf pancreas (age is 12 months, not above) or pigs involves freezing at temperature -40°C (not less), keeping at temperature -20-22°C for two months (not less) and adding 3% acetic acid solution in the volume ratio = 1:5 at temperature 20 ± 5°C. Extraction is carried out at constant stirring and 1% zinc chloride solution is added to the prepared homogenous suspension in the volume ratio = 50:1 followed by cooling at constant stirring to temperature 7-16°C and the following stirring for 1 h in each 4 h in settling for 48 h. Extract is separated from inert substances by separating and acetone is added to extract in the volume ratio = 1:5 and kept at temperature 3-5°C for 4 h. Formed homogenized deposit is precipitated with acetone repeatedly twice (not less) and deposit containing active substance is washed out on Nutch filter with two-fold volume of acetone cooled to temperature 7-16° up to preparing light-gray deposit. Deposit is rubbed through metallic sieve, dried, dissolved in distilled water at room temperature at constant stirring up to the concentration of polypeptides 2.5-2.9 mg/ml. Solution is centrifuged, filtered and subjected for ultrafiltration treatment in device under anti-pressure 1.0 kgf/cm2 (not above) through materials with retaining capacity 15000 Da. Glycocol is added to ultrafiltrate to its final concentration 10-20 mg/ml at pH = 5.6-6.6, solution is subjected for sterilizing filtration under pressure 2.0 kgf/cm2 (not above), poured into ampoules in volume 2 ml and subjected for autoclaving at temperature 120°C for 8 min and under atmosphere pressure 1.1 kgf/cm2. Invention provides optimal technology in isolating peptide complex from calf pancreas (age is 12 months, not above) or pigs with the content of low-molecular fraction from 70% to 90%, molecular mass of its peptide components in the range 74-228 Da, and preparing aqueous solution of extract with the concentration of polypeptides 2.5-2.9 mg/ml. Invention provides both purifying the prepared product from impurities and to enhance its yield. The isolated substance differs from the known substances early prepared from mammalian raw by molecular mass of its peptide components, absence of toxicity and apyretic properties based on the complete removing impurities.

EFFECT: improved preparing method, valuable properties of agent.

3 cl, 2 tbl, 1 dwg, 4 ex

Similar patents RU2302875C1

Title Year Author Number
AGENT NORMALIZING KIDNEY FUNCTION AND METHOD FOR ITS PREPARING 2006
  • Khavinson Vladimir Khatskelevich
  • Malinin Vladimir Viktorovich
  • Ryzhak Galina Anatol'Evna
RU2302868C1
AGENT NORMALIZING REPRODUCTIVE FUNCTION IN MEN AND METHOD FOR ITS PREPARING 2006
  • Khavinson Vladimir Khatskelevich
  • Malinin Vladimir Viktorovich
  • Ryzhak Galina Anatol'Evna
RU2302874C1
AGENT NORMALIZING CARTILAGE TISSUE FUNCTION AND METHOD FOR ITS PREPARING 2006
  • Khavinson Vladimir Khatskelevich
  • Malinin Vladimir Viktorovich
  • Ryzhak Galina Anatol'Evna
RU2302872C9
AGENT NORMALIZING BLADDER TONUS AND METHOD FOR ITS PREPARING 2006
  • Khavinson Vladimir Khatskelevich
  • Malinin Vladimir Viktorovich
  • Ryzhak Galina Anatol'Evna
RU2302867C1
PREPARATION FOR NORMALIZING FEMALE REPRODUCTIVE FUNCTION AND METHOD FOR ITS OBTAINING 2006
  • Khavinson Vladimir Khatskelevich
  • Malinin Vladimir Viktorovich
  • Ryzhak Galina Anatol'Evna
RU2303454C1
AGENT FOR NORMALIZING OF BLOOD-VESSEL FUNCTION AND METHOD FOR PRODUCTION THEREOF 2006
  • Khavinson Vladimir Khatskelevich
  • Malinin Vladimir Viktorovich
  • Ryzhak Galina Anatol'Evna
RU2301072C1
BRAIN FUNCTIONS NORMALIZING AGENT AND A METHOD FOR PREPARATION THEREOF 2006
  • Khavinson Vladimir Khatskelevich
  • Malinin Vladimir Viktorovich
  • Ryzhak Galina Anatol'Evna
RU2302871C1
HEPATOPROTECTIVE AGENT AND METHOD FOR PRODUCTION THEREOF 2006
  • Khavinson Vladimir Khatskelevich
  • Malinin Vladimir Viktorovich
  • Ryzhak Galina Anatol'Evna
RU2301071C1
GEROPROTECTOR ACTIVITY EXHIBITING AGENT AND A METHOD FOR PREPARATION THEREOF 2006
  • Khavinson Vladimir Khatskelevich
  • Malinin Vladimir Viktorovich
  • Ryzhak Galina Anatol'Evna
RU2302870C1
PEPTIDE NORMALIZING METABOLISM IN OSSEOUS AND CARTILAGE TISSUE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS USING 2006
  • Khavinson Vladimir Khatskelevich
  • Grigor'Ev Evgenij Iosifovich
  • Malinin Vladimir Viktorovich
  • Ryzhak Galina Anatol'Evna
RU2299741C1

RU 2 302 875 C1

Authors

Khavinson Vladimir Khatskelevich

Malinin Vladimir Viktorovich

Ryzhak Galina Anatol'Evna

Dates

2007-07-20Published

2006-06-22Filed